adenosine has been researched along with Allergic Encephalomyelitis in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Adzic Bukvic, M; Dragic, M; Laketa, D; Lavrnja, I; Nedeljkovic, N | 1 |
| Cai, Y; Chen, S; Du, C; Gao, Y; Lai, W; Qin, C; Yang, C; Zhou, J | 1 |
| Chen, S; Guo, J; Kong, F; Liu, G; Wang, Z; Zang, D; Zhang, W; Zhou, S | 1 |
| Hsuchou, H; Kastin, AJ; Mishra, PK; Ouyang, S; Pan, W; Wu, X | 1 |
| Loram, LC; Maier, SF; Rieger, J; Sloane, E; Strand, KA; Taylor, FR; Van Dam, AM; Watkins, LR | 1 |
| Aktas, O; Bauer, A; Graf, J; Hartung, HP; Hofrichter, M; Ingwersen, J; Lepka, K; Prozorovski, T; Schrader, J; Schröter, F; Wedekind, F; Wingerath, B | 1 |
| Kong, Q; Li, H; Liu, L; Liu, Y; Mu, L; Sun, B; Wang, D; Wang, G; Wang, J; Yin, P; Zhang, Y; Zhao, J; Zhao, P; Zhao, S; Zhao, X; Zou, H | 1 |
| Bynoe, MS; Ebisuno, Y; Mills, JH; Miyasaka, M; Takedachi, M; Tanaka, T; Thompson, LF | 1 |
| Bjelobaba, I; Lavrnja, I; Mostarica-Stojkovic, M; Nedeljkovic, N; Pekovic, S; Stojiljkovic, M; Stosic-Grujicic, S | 1 |
| Bjelobaba, I; Dacic, S; Lavrnja, I; Mostarica-Stojkovic, M; Nedeljkovic, N; Pekovic, S; Rakic, L; Stojiljkovic, M; Stojkov, D; Stosic-Grujicic, S | 1 |
| Di Penta, A; Fernandez-Diez, B; Moreno, B; Villoslada, P | 1 |
| Alabanza, LM; Bynoe, MS; Mahamed, DA; Mills, JH | 1 |
| Guo, S; Jia, Z; Li, Z; Ma, S; Xu, J; Xue, R | 1 |
| Henry, S; Noorbakhsh, F; Power, C; Schnermann, J; Tsutsui, S; Warren, K; Winston, BW; Yong, VW | 1 |
| Karlik, SJ; Messersmith, E; Meyer-Franke, A; Roscoe, WA; Wipke, B | 1 |
15 other study(ies) available for adenosine and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Expression of functionally distinct ecto-5'-nucleotidase/CD73 glycovariants in reactive astrocytes in experimental autoimmune encephalomyelitis and neuroinflammatory conditions in vitro.
Topics: 5'-Nucleotidase; Adenosine; Animals; Astrocytes; Central Nervous System; Encephalomyelitis, Autoimmune, Experimental | 2024 |
Critical Role of P2Y
Topics: Adenosine; Animals; Autoimmune Diseases; Cell Differentiation; Cells, Cultured; Clopidogrel; Colitis; Diabetes Mellitus, Experimental; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Gene Expression Regulation; Interleukin-17; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Knockout; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Signal Transduction; Th17 Cells; Ticagrelor; Ticlopidine; Trinitrobenzenesulfonic Acid | 2017 |
Adenosine binds predominantly to adenosine receptor A1 subtype in astrocytes and mediates an immunosuppressive effect.
Topics: Adenosine; Animals; Astrocytes; CD4-Positive T-Lymphocytes; Cells, Cultured; Coculture Techniques; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Female; Immunosuppressive Agents; Mice, Inbred C57BL; Mice, Knockout; Purinergic Agents; Receptor, Adenosine A1; RNA, Messenger | 2018 |
Loss of astrocytic leptin signaling worsens experimental autoimmune encephalomyelitis.
Topics: Adenosine; Animals; Astrocytes; Encephalomyelitis, Autoimmune, Experimental; Female; Hippocampus; Leukocytes; Mice; Mice, Knockout; Receptors, Leptin; Spinal Cord | 2013 |
Adenosine 2A receptor agonism: A single intrathecal administration attenuates motor paralysis in experimental autoimmune encephalopathy in rats.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Encephalomyelitis, Autoimmune, Experimental; Male; Microglia; Paralysis; Phenethylamines; Piperidines; Rats; Spinal Cord | 2015 |
Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
Topics: Adenosine; Animals; Anti-Inflammatory Agents; CD4-Positive T-Lymphocytes; Cell Movement; Cell Proliferation; Cells, Cultured; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Macrophages; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Myelin Proteolipid Protein; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Phagocytosis; Phenethylamines; Receptor, Adenosine A2A; Time Factors; Up-Regulation | 2016 |
Activation of the adenosine A2A receptor attenuates experimental autoimmune encephalomyelitis and is associated with increased intracellular calcium levels.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Body Weight; Calcium; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Immunologic Factors; Intracellular Space; Lymphocytes; Mice, Inbred C57BL; Myelin Sheath; Phenethylamines; Receptor, Adenosine A2A; Severity of Illness Index; Spinal Cord | 2016 |
Regulation of leukocyte migration across endothelial barriers by ECTO-5'-nucleotidase-generated adenosine.
Topics: 5'-Nucleotidase; Adenosine; Animals; Central Nervous System; Chemotaxis, Leukocyte; Encephalomyelitis, Autoimmune, Experimental; Endothelial Cells; Inflammation; Leukocytes; Lymph Nodes; Lymphatic Vessels; Mice; T-Lymphocytes | 2008 |
Time-course changes in ectonucleotidase activities during experimental autoimmune encephalomyelitis.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Apyrase; Cell Membrane; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Multiple Sclerosis; Rats; Rats, Inbred Strains; Spinal Cord; Time Factors | 2009 |
Ribavirin administration alters ectonucleotidase activities in experimental autoimmune encephalomyelitis.
Topics: 5'-Nucleotidase; Adenine Nucleotides; Adenosine; Animals; Anti-Inflammatory Agents; Cell Membrane; Encephalomyelitis, Autoimmune, Experimental; Female; Hydrolysis; Neuroprotective Agents; Rats; Ribavirin; Spinal Cord | 2009 |
Preclinical studies of methylthioadenosine for the treatment of multiple sclerosis.
Topics: Adenosine; Administration, Oral; Animals; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Female; Glatiramer Acetate; Glycoproteins; Half-Life; Immunologic Factors; Injections, Intraperitoneal; Interferon-beta; Mice; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Peptides; Rats; Rats, Sprague-Dawley; Thionucleosides | 2010 |
Extracellular adenosine signaling induces CX3CL1 expression in the brain to promote experimental autoimmune encephalomyelitis.
Topics: Adenosine; Animals; Brain; Cells, Cultured; Chemokine CX3CL1; Encephalomyelitis, Autoimmune, Experimental; Extracellular Fluid; Gene Expression Regulation; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Adenosine A2A; Signal Transduction | 2012 |
Additive effect of prostaglandin E2 and adenosine in mouse experimental autoimmune encephalomyelitis.
Topics: Adenosine; Analysis of Variance; Animals; Dinoprostone; Drug Synergism; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Female; Interferon-gamma; Interleukin-17; Mice; Mice, Inbred C57BL; Receptor, Adenosine A2A; Receptors, Prostaglandin E, EP4 Subtype; T-Lymphocytes; Time Factors | 2013 |
A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Caffeine; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Inflammation; Inflammation Mediators; Interleukin-1; Macrophages; Matrix Metalloproteinase 12; Metalloendopeptidases; Mice; Mice, Knockout; Microglia; Multiple Sclerosis; Myelin Sheath; Phenotype; Receptor, Adenosine A1; Recurrence; RNA, Messenger; Severity of Illness Index; Spinal Cord; Up-Regulation | 2004 |
Connexin 43 gap junction proteins are up-regulated in remyelinating spinal cord.
Topics: Adenosine; Animals; Antibodies; Connexin 43; Connexins; Encephalomyelitis, Autoimmune, Experimental; Female; Guinea Pigs; Integrin alpha4; Myelin Sheath; Nerve Regeneration; Recovery of Function; Spinal Cord; Up-Regulation | 2007 |